GlassScriptPhysician profile
Lynda M Smith
NPI 1053428516
$2,017.01
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,811 · 2022: $206.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $592.42 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $344.38 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $249.66 | 2021-2022 | |
| Abbvie INC. | $215.59 | 2021-2022 | |
| Incyte Corporation | $131.66 | 2021 | |
| Janssen Biotech, INC. | $99.73 | 2021-2022 | |
| Lilly USA, LLC | $97.71 | 2021 | |
| Leo Pharma INC. | $59.71 | 2021 | |
| Ucb, INC. | $58.21 | 2021-2022 | |
| Vyne Pharmaceuticals INC. | $39.91 | 2021 | |
| Amgen INC. | $38.25 | 2021 | |
| Mayne Pharma Commercial LLC | $23.36 | 2022 | |
| Epi Health, LLC | $19.28 | 2022 | |
| Genentech USA, INC. | $17.89 | 2021 | |
| Genzyme Corporation | $17.61 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.64 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.